Neuland Laboratories Dirección
Dirección controles de criterios 2/4
El CEO de Neuland Laboratories es Davuluri Rao , nombrado en Aug 2013, tiene una permanencia de 11.25 años. compensación anual total es ₹148.30M, compuesta por 16.3% salario y 83.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 3.3% de las acciones de la empresa, por valor de ₹6.81B. La antigüedad media del equipo directivo y de la junta directiva es de 4.2 años y 9.5 años, respectivamente.
Información clave
Davuluri Rao
Chief Executive Officer (CEO)
₹148.3m
Compensación total
| Porcentaje del salario del CEO | 16.3% |
| Permanencia del CEO | 11.3yrs |
| Participación del CEO | 3.3% |
| Permanencia media de la dirección | 4.2yrs |
| Promedio de permanencia en la Junta Directiva | 9.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14
Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Neuland Laboratories Limited's (NSE:NEULANDLAB) Shares Climb 44% But Its Business Is Yet to Catch Up
Aug 22Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?
Aug 02Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00
Jul 12Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking
Jul 02Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹3b |
| Jun 30 2024 | n/a | n/a | ₹3b |
| Mar 31 2024 | ₹148m | ₹24m | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹3b |
| Sep 30 2023 | n/a | n/a | ₹3b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹58m | ₹20m | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹1b |
| Sep 30 2022 | n/a | n/a | ₹831m |
| Jun 30 2022 | n/a | n/a | ₹651m |
| Mar 31 2022 | ₹30m | ₹15m | ₹638m |
| Dec 31 2021 | n/a | n/a | ₹593m |
| Sep 30 2021 | n/a | n/a | ₹731m |
| Jun 30 2021 | n/a | n/a | ₹742m |
| Mar 31 2021 | ₹34m | ₹11m | ₹806m |
| Dec 31 2020 | n/a | n/a | ₹540m |
| Sep 30 2020 | n/a | n/a | ₹384m |
| Jun 30 2020 | n/a | n/a | ₹257m |
| Mar 31 2020 | ₹22m | ₹10m | ₹162m |
| Dec 31 2019 | n/a | n/a | ₹321m |
| Sep 30 2019 | n/a | n/a | ₹257m |
| Jun 30 2019 | n/a | n/a | ₹216m |
| Mar 31 2019 | ₹13m | ₹10m | ₹164m |
| Mar 31 2018 | ₹5m | ₹3m | ₹121m |
Compensación vs. Mercado: La compensación total de Davuluri($USD1.76M) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD610.84K).
Compensación vs. Ingresos: La compensación de Davuluri ha aumentado más de un 20% en el último año.
CEO
Davuluri Rao (49 yo)
11.3yrs
Permanencia
₹148,300,000
Compensación
Mr. Davuluri Sucheth Rao has been the Chief Executive Officer of Neuland Laboratories Limited since August 1, 2013, where Mr. Rao also served as its Chief Operating Officer. At Neuland, Sucheth has been re...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & Chief Promoter and Member of Scientific Advisory Board | 40.8yrs | ₹148.50m | 26.37% ₹ 54.4b | |
| Vice Chairman & CEO | 11.3yrs | ₹148.30m | 3.3% ₹ 6.8b | |
| Vice Chairman & MD | 15.4yrs | ₹148.30m | 2.24% ₹ 4.6b | |
| Chief Financial Officer | 2yrs | sin datos | sin datos | |
| Chief Scientific Officer & Member of Scientific Advisory Board | less than a year | sin datos | sin datos | |
| Company Secretary & Compliance Officer | 12.8yrs | sin datos | sin datos | |
| Senior VP of Global Head Sales & BD | no data | sin datos | sin datos | |
| Chief Human Resources Officer | no data | sin datos | sin datos | |
| Senior Vice President of Global API Sales | no data | sin datos | sin datos | |
| Chief Procurement Officer | no data | ₹6.81m | sin datos | |
| President of Business Development & Contract Manufacturing | no data | sin datos | sin datos | |
| Chief Quality Officer | less than a year | sin datos | sin datos |
4.2yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de NEULANDLAB se considera experimentado (4.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & Chief Promoter and Member of Scientific Advisory Board | 40.8yrs | ₹148.50m | 26.37% ₹ 54.4b | |
| Vice Chairman & CEO | 21.3yrs | ₹148.30m | 3.3% ₹ 6.8b | |
| Vice Chairman & MD | 15.4yrs | ₹148.30m | 2.24% ₹ 4.6b | |
| Chief Scientific Officer & Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 2yrs | ₹2.90m | 0.00062% ₹ 1.3m | |
| Non-Executive Independent Director | 5.8yrs | ₹3.24m | sin datos | |
| Independent Director | 1.3yrs | ₹2.82m | sin datos | |
| Non-Executive Director & Member of Scientific Advisory Board | 15.1yrs | ₹2.85m | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Non-Executive Independent Director | 9.5yrs | ₹3.16m | sin datos | |
| Independent Director | 1.3yrs | ₹2.82m | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
9.5yrs
Permanencia media
78yo
Promedio de edad
Junta con experiencia: La junta directiva de NEULANDLAB se considera experimentada (9.5 años de antigüedad promedio).